MDxHealth SA SEC filings MDXH

MDxHealth SA has 183 filings in SEC EDGAR's recent list, going back to Aug 9, 2021. Its latest annual report, Form 20-F, was filed on Apr 3, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Oct 30, 2026.

MDxHealth SA SEC filings
Form Description Filed Period
EFFECT Filing Feb 17, 2026 —
CORRESP Letter to the SEC Feb 12, 2026 —
UPLOAD Letter from the SEC Jan 6, 2026 —
EFFECT Filing Jul 10, 2024 —
CORRESP Letter to the SEC Jul 8, 2024 —
UPLOAD Letter from the SEC Jul 2, 2024 —
8-A12B/A Amendment no. 1 to form 8-a12b Nov 24, 2023 —
25-NSE Delisting notice Nov 24, 2023 —
EFFECT Filing Dec 30, 2022 —
CORRESP Letter to the SEC Dec 28, 2022 —
UPLOAD Letter from the SEC Dec 27, 2022 —
D Filing Aug 15, 2022 —
SEC STAFF LETTER Filing Nov 4, 2021 —
EFFECT Filing Nov 3, 2021 —
CERT Filing Nov 3, 2021 —
CORRESP Letter to the SEC Nov 1, 2021 —
CORRESP Letter to the SEC Nov 1, 2021 —
8-A12B For registration of certain classes Nov 1, 2021 —
CORRESP Letter to the SEC Nov 1, 2021 —
UPLOAD Letter from the SEC Oct 29, 2021 —
CORRESP Letter to the SEC Oct 13, 2021 —
UPLOAD Letter from the SEC Oct 8, 2021 —
DRS/A Filing Sep 23, 2021 —
DRSLTR Filing Sep 22, 2021 —
SEC STAFF LETTER Filing Sep 10, 2021 —
UPLOAD Letter from the SEC Sep 7, 2021 —
DRS Filing Aug 9, 2021 —

Showing 27 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Services-Medical Laboratories (SIC 8071)
Listed as
MDXH (Nasdaq)
Incorporated in
Belgium
Headquarters
Herstal, Belgium
SEC filer status
Non-accelerated filer, Emerging growth company
SEC CIK
1872529

Other Services-Medical Laboratories companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.